CAS: 2812-46-6; H-Pro-Otbu

该化合物是一种作为有机合成和制药应用中的关键中间体而广泛使用的一种手性丙烯二醇衍生物,其乙基丁基酯组群增强了稳定性和溶性,便利了处理和净化过程. (2S)配置提供了立体化学控制,使其对非对称合成和生物活性化合物的制备具有价值.该化合物在化和培养蛋白抑制剂方面特别有用.其坚固的结构能确保与一系列反应条件相容,包括核生殖器替代和减少.高纯度可以满足严格的研究和工业要求."

结构式图片

相似化合物

5497-76-7 90071-62-8 184719-80-0

欧盟法规

ECHA物质C&L通报REACH预注册

上下游产品

CAS号16881-39-3 N-Cbz-L-脯氨酸叔丁酯 | CAS号91237-84-2 (2S)-5-氧代-1,2-吡... | CAS号115-11-7 2-甲基丙烯 | CAS号147-85-3 脯氨酸 | CAS号5497-76-7 L-脯氨酸特丁酯盐酸盐 | CAS号1148-11-4 N-CBZ-L-脯氨酸 | CAS号81477-94-3 二苯亚甲基甘氨酸叔丁酯 | CAS号79640-72-5 (S)-5-甲基-2-氨基戊二酸叔丁酯 | CAS号217326-48-2 N-(3,5-二氯苯磺酰基)-l-脯氨酸 | CAS号7776-34-3 L-脯氨酸盐酸盐 | CAS号76095-16-4 马来酸依那普利 | CAS号62571-86-2 卡托普利 | CAS号5497-76-7 L-脯氨酸特丁酯盐酸盐 | CAS号75847-73-3 依那普利 | CAS号360045-22-3 1-(甲基磺酰基)-l-脯氨酸 | CAS号129223-22-9 N-芴甲氧羰基-脯氨酰-脯氨酸 | CAS号5874-58-8 N-苯甲酰基-l-脯氨酸

合成工艺路线路线简述

    D-脯氨酸 反应生成D-脯氨酸叔丁酯
    参考文献:D-Proline Derivatives
    标题:D-Proline Derivatives
    摘要:新化合物的化学式为:##str1## 其中r,R.Sup.1,X和y的含义如本文所述.本文提供了合成这些化合物和使用这些化合物治疗与淀粉样变性相关的疾病的方法,如阿尔茨海默病,成人起病糖尿病,家族性淀粉样多发性神经病,痱子病和克雅氏病.

    海关参考信息

    专利信息


    专利号:US-2009099061-A1
    优先权日:2006-01-27
    标 题:Synthesis of carotenoid analogs or derivatives with improved antioxidant characteristics
    发明人:FOSS BENTE J; NADOLSKI GEOFFRY T; LOCKWOOD SAMUEL F
    权利人:FOSS BENTE J; NADOLSKI GEOFFRY T; LOCKWOOD SAMUEL F
    摘要:A method is described for synthesizing and administering carotenoid compounds with improved antioxidant characteristics. In some embodiments, extension or improvement of conjugation may be employed in structural modification of carotenoids. In other embodiments, reduction of ring/chain steric hindrance may improve the lambda max, and hence, the overall antioxidant capability, of particular compounds. In other embodiments, introduction and/or increase in synthetic handles for conjugation may improve the stoichiometric ratios of conjugating moieties to the polyene backbone. The methods may be used to improve natural and/or synthetic compounds for medicinal application in the treatment of disease.

    专利号:US-6797820-B2
    优先权日:1999-12-17
    标 题:Succinate compounds, compositions and methods of use and preparation
    发明人:PATEL DINESH; JACOBS JEFFREY W; JAIN RAKESH; NI ZHI-JIE; YUAN ZHENGYU
    权利人:VICURON PHARM INC
    摘要:Novel hydroxamic acid compounds are disclosed. These hydroxamates inhibit peptidyl deformylase (PDF), an enzyme present in prokaryotes. The hydroxymates are useful as antimicrobials and antibiotics. The compounds of the invention display selective inhibition of peptidyl deformylase versus other metalloproteinases such as matrix metalloproteinases (MMPs). Methods of synthesis and of use of the compounds are also disclosed.

    专利号:WO-0144179-A1
    优先权日:1999-12-17
    标题 :Novel succinate compounds, compositions and methods of use and preparation
    发明人:JAIN RAKESH; NI ZHI-JIE; PATEL DINESH V; YUAN ZHENGYU
    权利人:VERSICOR INC; JACOBS JEFFREY W; JAIN RAKESH; NI ZHI JIE; PATEL DINESH V; YUAN ZHENGYU
    摘要:Novel hydroxamic acid compounds of Formula (I) are disclosed. These hydroxamates inhibit peptide deformylase (PDF), an enzyme present in prokaryotes. The hydroxymates are useful as antimicrobials and antibiotics. The compounds of the invention display selective inhibition of peptidyl deformylase versus other metalloproteinases such as matrix metalloproteinases (MMPs). Methods of synthesis and of use of the compounds are also disclosed.

    专利号:US-8338565-B2
    优先权日:2008-08-20
    标 题 :Macrocyclic compounds for inhibition of tumor necrosis factor alpha
    发明人:LEE JINBO; BOND JULIAN F; TERRETT NICHOLAS; FAVALORO JR FRANK G; WANG DANIEL; BRIGGS TIMOTHY F; SEIGAL BENJAMIN ADAM; SUN WEI-CHUAN; HALE STEPHEN P
    权利人:LEE JINBO; BOND JULIAN F; TERRETT NICHOLAS; FAVALORO JR FRANK G; WANG DANIEL; BRIGGS TIMOTHY F; SEIGAL BENJAMIN ADAM; SUN WEI-CHUAN; HALE STEPHEN P; ENSEMBLE THERAPEUTICS CORP
    摘要:Disclosed herein are macrocyclic compounds and methods for their synthesis and use. In particular, macrocyclic compounds are disclosed that modulate the activity of tumor necrosis factor alpha and/or are useful in the treatment of medical conditions, such as, rheumatoid arthritis, psoriasis, and asthma.

    专利号:US-6852752-B2
    优先权日:1999-12-17
    标 题:Urea compounds, compositions and methods of use and preparation
    发明人:JACOBS JEFFREY W; PATEL DINESH; LEWIS JASON; NI ZHI-JIE
    权利人:VICURON PHARM INC
    摘要:Novel hydroxamic acid compounds are disclosed. These hydroxamates inhibit peptide deformylase (PDF), an enzyme present in prokaryotes and are therefore useful as antimicrobials and antibiotics. Methods of synthesis and of use of the compounds are also disclosed.

    专利号:CN-107840850-A
    优先权日:2017-09-30
    标 题 :A large-scale synthesis and preparation method of (±)-macahydantoin revised B
    南京新斯特生物科技有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.nstbio.com
    企业联系电话:025-85331029,18915981017👤
    📞南京新斯特生物科技有限公司 ⚠️参考联系方式
    联系人:杨女士
    电话:025-85331029,18915981017
    手机:18915981017
    传真:025-85331829
    邮箱:sales@nstbio.com
    通信地址: 江苏省南京市栖霞区纬地路9号江苏省生命科技创新园F6栋10楼
    邮编: 210010
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    地址:江苏省南京市栖霞区纬地路9号江苏省生命科技创新园F6栋10楼
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
    ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    上海庭园生化科技有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.gdbiochem.com.cn
    电话: 021-50800786👤
    📞上海庭园生化科技有限公司 ⚠️参考联系方式

    销售电话:021-50800786
    邮箱:sales@gdbiochem.com.cn
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别 ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    第 1 / 1 页
    现货

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    主要参考文献

    参考标题:Allenone-Mediated Racemization/epimerization-Free Peptide Bond Formation And Its Application In Peptide Synthesis
    作者:Zhengning Wang,Xuewei Wang,Penghui Wang,Junfeng Zhao |发布日期:2021.7.14
    摘要:Peptide Synthesis (Spps). The Robustness Of The Allenone-Mediated Peptide Bond Formation Was Showcased Incisively By The Synthesis Of Carfilzomib, Which Involved A Rare Racemization-/epimerization-Free N To C Peptide Elongation Strategy. Furthermore, The Successful Synthesis Of The Model Difficult Peptide Acp (65-74) On A Solid Support Suggested That This Method Was Compatible With Spps. This Method Combines

    合成参考文献


    摘要:Aguilar, E.; López, L. A., Science of Synthesis Knowledge Updates, (2014) 2, 9.
    摘要:Crousse, B., Science of Synthesis: Modern Strategies in Organofluorine Chemistry , (2024) 1, 2.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知